InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by McMeans Shaun D, Chief Financial Officer. Officer active across 1 companies, notably HTG Molecular Diagnostics, INC. In total, 13 filings have been logged. The latest transaction was disclosed on 30 June 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€2929 shares@ €0.9830.4% of flow
Common Stock
SEC:0001209191-22-040340:0·
€4481,000 shares@ €0.44825.8% of flow
Common Stock
SEC:0001209191-22-036958:0·
€3931 shares@ €1.25540.5% of flow
Common Stock
SEC:0001209191-22-022376:0·
€14831 shares@ €4.78594.1% of flow
Common Stock
SEC:0001209191-22-000847·
€14831 shares@ €4.78591.9% of flow
Common Stock
SEC:0001209191-22-000847:0·
€1,640520 shares@ €3.153645.5% of flow
Common Stock
SEC:0001209191-21-069772·
€1,640520 shares@ €3.153621.2% of flow
Common Stock
SEC:0001209191-21-069772:0·
€15331 shares@ €4.93334.2% of flow
Common Stock
SEC:0001209191-21-059009·
€15331 shares@ €4.93332.0% of flow
Common Stock
SEC:0001209191-21-059009:0·
€15231 shares@ €4.90024.2% of flow
Common Stock
SEC:0001209191-21-045184·
€15231 shares@ €4.90022.0% of flow
Common Stock
SEC:0001209191-21-045184:0·
€1,510469 shares@ €3.219141.9% of flow
Common Stock
SEC:0001209191-21-040444·
€1,510469 shares@ €3.219119.6% of flow
Common Stock
SEC:0001209191-21-040444:0·
13 of 13 declarations
About McMeans Shaun D
McMeans Shaun D serves as Chief Financial Officer and Senior Vice President of Finance & Administration at HTG Molecular Diagnostics, Inc. He oversees the company's financial management, ensuring compliance and transparency in financial operations. His expertise is crucial for supporting the company's strategy.
